Paysign, Inc.

PAYS
About the company

Paysign, Inc. provides prepaid card programs, patient affordability offerings, digital banking, life science software technology solutions, and integrated payment processing services for businesses, consumers, and government institutions in the United States.

Country: United StatesPrice: $9.52Market Cap: $541.3M

Investment snapshot

53%positive consensus
Scored 1d ago

Positive

8

BUY / PASS

Neutral / negative

2 / 6

NEUTRAL / FAIL

Median fair value

$3.25

-65.9% vs price

Models with upside

2 / 17

Positive margin of safety

Strongest signal

8 of 10 pass — Dreman and Pabrai object

Key risk

11 of 13 flag PAYS's valuation — Graham, Greenblatt, Dreman +8 more

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILBUYBUY · Rank #480 (Top 15.5%)NEUTRALPASSPASSFAILPASSFAILBUYPASSPASSBUYFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/A
Margin of Safety-495.0%-44.9%-192.9%-2341.0%N/A-495.0%+57.1%-107.0%-0.5%-1663.0%+71.4%-994.3%N/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Annual history · FY 2025

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-25

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30 · TTM ended 2026-09-30 vs 2025-09-30 · TTM ended 2026-09-30

Latest source filing: 2026-11-10

Score computed: 2026-11-14

TTM ended 2026-09-30

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-25

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-03-25

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-25

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-25

Score computed: 2026-11-14

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-10

Score computed: 2026-11-14

TTM ended 2026-09-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Where It Passes

  • Cash Flow80% pass✓ 10✗ 2▾

    8 of 10 pass — Dreman and Pabrai object

    Free Cash Flow Proxy$14.7M
    ✓BuffettPositive and growing
    FCF Positive and Growing$129.9M
    ✓LynchPositive and growing
    Operating Cash Flow$52.5M
    ✓PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=18.99%, ROA=2.73%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)10.0x
    ✗Dreman< 8x
    P/E or FCF YieldP/E=73.2x, FCF Yield=9.5%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive14/16 years FCF positive
    ✓MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap24.7%
    ✓Ackman>= 4%
    Price / FCF per Share10.2x
    ✓Ackman<= 25
    Positive Operating Cash Flow frequency14/16 years positive
    ✓SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$129.9M
    ✓Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization+24.00%; #238/4519 (top 5.3%)
    ✓OshaughnessyTop 10% of eligible cross-section
  • Debt & Leverage67% pass✓ 11✗ 4▾

    8 of 12 pass — Buffett, Piotroski, Dreman +1 more object

    LT Debt vs Net Current AssetsLT Debt $3.6M vs NCA $42.0M
    ✓GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 0.17, IC: N/A
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity0.08
    ✓Lynch< 0.33
    Cash - Long-term Debt$31.0M
    ✓LynchPositive preferred
    LT Debt / Total Assets Change0.00% -> 2.22%
    ✗PiotroskiDecreased YoY
    Current Assets / Current Liabilities1.15
    ✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity0.08
    ✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
    Debt Levels0.08
    ✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=N/A (no interest expense), D/EBITDA=0.5x
    ✓MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity0.08
    ✓Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-0.0807; #1186/4210 (top 28.2%)
    ✓AsnessTop 30% of eligible cross-section
  • Growth63% pass✓ 10✗ 3▾

    5 of 8 pass — Graham, Sleep and Neff object

    EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)0.85
    ✓Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR86.6%
    ✓Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthN/A (no inventory)
    ✓LynchInventory growth < Revenue growth
    EPS Growth Direction$0.00 (2011) -> $0.13 (2025)
    ✓DremanPositive over recent years
    EPS CAGR7.6% CAGR over 13 years
    ✓Dreman> 5% annualized
    Positive Net Income Frequency12/16 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth24.3%
    ✓Ackman>= 5%
    Positive EPS Growth Frequency4/5 years with positive EPS growth
    ✓AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR86.6% CAGR over 3 years
    ✓Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendgross margin 51.1% -> 59.4%, operating margin -0.4% -> 9.0%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR27.7%
    ✓SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR86.6% over 3 years
    ✗Neff7%-20% annualized
  • Verdicts60% pass✓ 9✗ 6▾

    Split decision: 6 FAIL · 5 PASS · 3 BUY · 2 NEUTRAL

    Overall verdict
    ✗GrahamFAIL (2/9)✗BuffettFAIL (3/9)✓LynchBUY (7/7)✓GreenblattRank #480•PiotroskiNEUTRAL (F-Score 6)✓DremanPASS (5/11)✓MungerPASS (2/4)✗PabraiFAIL (0/3)✓AkrePASS (3/6)✗MarksFAIL (3/5)✓AckmanBUY (8/9)✓TempletonPASS (4/8)✓SleepPASS (3/6)✓AsnessBUY (Rank #206/2370 (Top 8.7%))✗NeffFAIL (2/6)✗SchlossFAIL (3/7)•OshaughnessyNEUTRAL (Not ranked)

Where It Falls Short

  • Valuation15% pass✓ 4✗ 24▾

    11 of 13 flag PAYS's valuation — Graham, Greenblatt, Dreman +8 more

    Price / 3-yr avg EPS89.3x
    ✗Graham<= 15x
    Price-to-Book Ratio10.8x
    ✗Graham<= 1.5x
    P/E x P/B966.10
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)0.85
    ✓Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value4.5%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=4.5%, ROC=206.8%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS73.2x
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)10.0x
    ✗Dreman< 8x
    Price / Book Value per Share10.8x
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessP/E=73.2x, OE Yield=2.8%
    ✗MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldP/E=73.2x, FCF Yield=9.5%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/E=73.2x, P/B=10.8x
    ✗MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic Value-495.0% (IV=$1.60 vs Price=$9.52)
    ✗Marks>= 20% below intrinsic value
    Price / FCF per Share10.2x
    ✓Ackman<= 25
    Price vs. Trailing Low449% of trailing low ($2.12)
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization+3.75%; #2110/6340 (top 33.3%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+0.1226; #4622/6449 (top 71.7%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS73.2x
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per Share24.24x
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change+233.5%
    ✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+0.2029; #3769/5247 (top 71.8%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization+24.00%; #238/4519 (top 5.3%)
    ✓OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date+45.12%; #725/6202 (top 11.7%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Valuation models18% pass✓ 2✗ 9▾

    Models split on PAYS at $9.52 — fair values range $0.39–$33.29

    Graham fair value$1.60
    ✗Graham-495.0% margin vs $9.52
    Buffett fair value$6.57
    ✗Buffett-44.9% margin vs $9.52
    Lynch fair value$3.25
    ✗Lynch-192.9% margin vs $9.52
    Greenblatt fair value$0.39
    ✗Greenblatt-2341.0% margin vs $9.52
    Dreman fair value$1.60
    ✗Dreman-495.0% margin vs $9.52
    Munger fair value$22.17
    ✓Munger+57.1% margin vs $9.52
    Pabrai fair value$4.60
    ✗Pabrai-107.0% margin vs $9.52
    Akre fair value$9.47
    ✗Akre-0.5% margin vs $9.52
    Marks fair value$0.54
    ✗Marks-1663.0% margin vs $9.52
    Ackman fair value$33.29
    ✓Ackman+71.4% margin vs $9.52
    Templeton fair value$0.87
    ✗Templeton-994.3% margin vs $9.52
  • Profitability38% pass✓ 18✗ 17▾

    10 of 16 flag PAYS's profitability — Graham, Buffett, Greenblatt +7 more

    Positive EPS (10 years)11/17 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)12/17 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)8.0%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)9.0% (latest)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy$14.7M
    ✓BuffettPositive and growing
    Earnings Variance (10-yr CoV)2.43
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)0.85
    ✓Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR86.6%
    ✓Lynch15-30% (Fast Grower); > 0% to pass
    ROE30.6%
    ✓Lynch> 15%
    EBIT / Enterprise Value4.5%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=4.5%, ROC=206.8%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets2.73%
    ✓PiotroskiROA > 0
    ROA Change YoY2.13% -> 2.73% (delta: +0.60%)
    ✓PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=18.99%, ROA=2.73%
    ✓PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY55.1% -> 59.4%
    ✓PiotroskiImproved YoY
    Pre-Tax Income / Revenue23.7%
    ✓Dreman>= 8%
    Net Income / Shareholders' Equity30.6%
    ✓Dreman> 12%
    Margin of SafetyP/E=73.2x, P/B=10.8x
    ✗PabraiP/B < 1.5 or P/E < 15
    Return on Equity18.2% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic Value-495.0% (IV=$1.60 vs Price=$9.52)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency12/16 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue20.8%
    ✓Ackman>= 15%
    Net Income / Shareholders Equity30.6%
    ✓Ackman>= 15%
    5-Year EPS CAGR86.6% CAGR over 3 years
    ✓Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend-0.4% (2023) -> 9.0% (2025)
    ✓TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendgross margin 51.1% -> 59.4%, operating margin -0.4% -> 9.0%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization+3.75%; #2110/6340 (top 33.3%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets+19.90%; #2066/3702 (top 55.8%)
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity+30.58%; #435/5226 (top 8.3%)
    ✓AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.0257; #1726/5884 (top 29.3%)
    ✓AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR86.6% over 3 years
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years8/10 years positive
    ✓Schloss>= 70% positive over 5-10 observed years (app rule)
  • Efficiency38% pass✓ 6✗ 5▾

    5 of 8 flag PAYS's efficiency — Graham, Piotroski, Dreman +2 more

    Current Ratio1.15
    ✗Graham>= 2.0
    ROIC (3-5 yr avg)29.0%
    ✓Buffett> 10%
    ROIC - WACC+19.0%
    ✓BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)206.8%
    ✓Greenblatt> 25%
    Current Ratio Change YoY1.09 -> 1.11
    ✓PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY0.33x -> 0.30x
    ✗PiotroskiImproved YoY
    Current Assets / Current Liabilities1.15
    ✗Dreman> 1.5
    Return on Invested Capital25.2%
    ✓Munger> 15%
    ROIC (high and growing)FY2023: ROIC=unavailable; FY2024: ROIC=2.7%; FY2025: ROIC=10.3%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROIC10.3% (RR=100% x ROIC=10.3%)
    ✓AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)0/2 years above 12% (latest 10.3%)
    ✗SleepROIC > 12% in a majority of years

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Business Services
Size: Small Cap($541.3M)
Revenue: $82.0M+40.5% YoY
Net Income: $7.6M+97.9% YoY

Financial Snapshot

Operating Margin9.0%
Return on Equity15.6%
Debt / Equity0.17
Current Ratio1.11
EPS (Diluted)$0.13+85.7% 1y
Buybacks (1y)$375.8K
Buybacks (2y)$870.8K
Shares Retired−2.8% / −4.3% 2y

Shareholder Return

Fiscal 2025

Issued 2.8% of shares last year, 4.3% issued over two.

Buybacks
$375.8K
Dividends
—

What drove EPS

A buyback raises earnings per share without the company earning more. This splits each year's change into the two.

FY23
500.0% = 528.4% + −4.5%
FY24
−41.7% = −40.9% + −1.3%
FY25
85.7% = 97.9% + −6.2%
Earnings Fewer shares More shares

The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.

Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-09-30

2025-10-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: revenue, net income, operating income, gross profit, ebit, pre tax income, operating cash flow, depreciation amortization, capex, buybacks.

Q3 FY 2026

2026-07-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, depreciation amortization, capex, buybacks.

Q2 FY 2026

2026-04-01 – 2026-06-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, depreciation amortization, capex.

Q1 FY 2026

2026-01-01 – 2026-03-31

Sources
FY 2025
Sources
  • 10-K · 2026-03-25
FY 2024
Sources
  • 10-K · 2025-03-26
FY 2023
Sources
  • 10-K · 2024-03-27
FY 2022
Sources
  • 10-K · 2023-03-22
FY 2021
Sources
  • 10-K · 2022-03-23
Market Cap$541.3Mcurrent------$229.9Mest.$142.7Mest.$162.3Mest.$181.8Mest.$115.1Mest.
Revenue$109.8M↑47%$30.8M↑43%$28.3M↑48%$28.0M↑51%$82.0M↑40%$58.4M↑24%$47.3M↑24%$38.0M↑29%$29.5M
Operating Income$22.9M↑283%$7.3M↑363%$7.0M↑388%$6.7M↑168%$7.4M↑621%$1.0M↑711%-$167.3K↓149%$344.3K↑113%-$2.7M
Net Income$20.3M↑168%$6.7M↑204%$6.8M↑387%$5.4M↑110%$7.6M↑98%$3.8M↓41%$6.5M↑528%$1.0M↑138%-$2.7M
EPS (Diluted)--$0.11↑175%$0.11↑450%$0.09↑80%$0.13↑86%$0.07↓42%$0.12↑500%$0.02↑140%$-0.05
Gross Margin63.0%↑5%64.7%↑15%63.3%↑3%65.0%↑3%59.4%↑8%55.1%↑8%51.1%↓7%55.1%↑10%49.9%
Operating Margin20.8%↑161%23.8%↑224%24.8%↑229%23.8%↑78%9.0%↑413%1.7%↑595%-0.4%↓139%0.9%↑110%-9.3%
ROE30.6%↑85%———15.6%↑24%12.5%↓52%26.4%↑318%6.3%↑130%-21.0%
Total Debt$5.4M↓32%$5.4M↓32%$5.3M↓32%$6.1M↓37%$8.0M$0------
Shareholders' Equity$66.4M↑45%$66.4M↑45%$60.2M↑43%$55.0M↑40%$48.5M↑59%$30.4M↑24%$24.5M↑50%$16.3M↑25%$13.0M
Current Ratio1.15↑2%1.15↑2%1.14↑3%1.12↑4%1.11↑2%1.091.08↓2%1.101.10
Debt / Equity0.08↓53%0.08↓53%0.09↓52%0.11↓55%0.170.00———
Operating Cash Flow$130.9M↑601%$62.8M↑829%$1.3M↓64%$18.8M↑411%$52.5M↑129%$22.9M↓17%$27.6M↑9%$25.3M↑66%$15.2M
Free Cash Flow$129.9M↑624%$62.7M↑895%$1.2M↓66%$18.5M↑403%$51.2M↑128%$22.5M↓18%$27.4M↑9%$25.2M↑69%$14.9M

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Business Services

PAYS vs Peers — Financial Grading

Revenue$82.0MBottom 25%
Net Income$7.6MMedian
ROE15.6%Median
D/E0.17Top 25%
Op. Margin9.0%Top 25%
Curr. Ratio1.11Median
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
AUTOMATIC DATA PROCESSING INCADP$122.3B$309.93$21.9B$4.4B73.2%0.8224.2%1.054/95/93/70/3F-Score 65/11
ELECTRONIC ARTS INC.EA$52.9B$209.70$7.5B$887.0M13.1%0.2215.4%1.051/94/94/70/3F-Score 66/11
Rubrik, Inc.RBRK$22.6B$109.88$1.3B$348.8M67.1%—-26.2%1.691/90/92/70/3F-Score 62/11
AECOMACM$9.1B$70.50$16.1B$561.8M22.5%1.096.4%1.141/93/93/71/3F-Score 82/11
COMMVAULT SYSTEMS INCCVLT$6.2B$152.07$1.2B$70.7M942.8%—6.3%1.951/92/94/70/3F-Score 66/11
WPP plcWPP$6.0B$27.79$18.2B$289.5M-8.5%1.942.8%0.891/92/91/70/3F-Score 32/11
VARONIS SYSTEMS INCVRNS$5.6B$48.94$623.5M$129.3M-21.6%0.76-23.5%1.971/90/91/70/3F-Score 51/11
ROBERT HALF INC.RHI$4.3B$42.00$5.4B$133.0M10.4%—1.4%1.532/95/91/70/3F-Score 52/11